Because Bcl-2 family members play a role in determining the sensitivity of cancer cells to gemcitabine [34,35], we examined the expressions of anti-apoptotic Bcl-2, Bcl-xL, and Bfl-1 by RT-PCR. This evidence concerns the gene BCL2L1 and cancer.